![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/AAREYDRUGS.png)
Share the post "Aarey Drugs & Pharmaceuticals ‘s Q2 Update: Profit Grows by 102.53% YoY"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 81.81 % in the past year, decrease in net sales/revenue by -17.15 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -97.6 %, Marginal decrease of -98.73% in other income during this quarter.
- Profit over the Year and quarter: Significant improvement in profitability for Aarey Drugs & Pharmaceuticals Limited. Notable increase of 103.44 % in net profit Year to Year, Aarey Drugs & Pharmaceuticals Limited’s profitability increased by 28.89 % in this quarter.
- EPS over the Year and quarter: EPS increased by 267.74 % Year to Year. EPS increased by 29.55 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 57.831 Cr | Rs. 126.912 Cr | Rs. 105.144 Cr | -17.15 % | + 81.81 % |
| Expenses | Rs. 55.98 Cr | Rs. 125.73 Cr | Rs. 101.42 Cr | -19.34 % | + 81.17 % |
| Operating Profit | Rs. 1.85 Cr | Rs. 1.18 Cr | Rs. 3.72 Cr | + 215.25 % | + 101.08 % |
| OPM % | 3.2 % | 0.93 % | 3.54 % | + 2.61 % | + 0.34 % |
| Other Income | Rs. 0.835 Cr | Rs. 1.575 Cr | Rs. 0.02 Cr | -98.73 % | -97.6 % |
| Interest | Rs. 1.27 Cr | Rs. 0.96 Cr | Rs. 1.51 Cr | + 57.29 % | + 18.9 % |
| Depreciation | Rs. 0.41 Cr | Rs. 0.47 Cr | Rs. 0.49 Cr | + 4.26 % | + 19.51 % |
| Profit before tax | Rs. 1.01 Cr | Rs. 1.33 Cr | Rs. 1.74 Cr | + 30.83 % | + 72.28 % |
| Tax % | 22.05 % | 6.91 % | 8.59 % | + 1.68 % | -13.46 % |
| Net Profit | Rs. 0.79 Cr | Rs. 1.24 Cr | Rs. 1.6 Cr | + 29.03 % | + 102.53 % |
| EPS in Rs | Rs. 0.31 | Rs. 0.88 | Rs. 1.14 | + 29.55 % | + 267.74 % |
Today, we’re looking at Aarey Drugs & Pharmaceuticals Limited’s financial performance for the Q2(Sep 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 81.81 %. However, it did see a marginal slip of -17.15 % from the previous quarter. Expenses decreased slightly by -19.34 % quarter-on-quarter, aligning with the annual rise of 81.17 %. Operating profit, while up 101.08 % compared to last year, faced a quarter-on-quarter increase of 215.25 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 0.34 %, but an expansion of 2.61 % sequentially. Other income fell by -98.73 % compared to the last quarter, despite an annual decline of -97.6 %. Interest expenses surged remarkably by 57.29 % from the previous quarter, yet the year-over-year increase remains at a moderate 18.9 %. Depreciation costs climbed by 4.26 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 19.51 %. Profit before tax grew annually by 72.28 % but saw an increase from the preceding quarter by 30.83 %.
Tax expenses as a percentage of profits decreased slightly by -13.46 % compared to last year, with a more notable quarter-on-quarter increase of 1.68 %. Net profit rose by 102.53 % year-on-year but experienced a 29.03 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 267.74 % but a quarterly rise of 29.55 %. In summary, Aarey Drugs & Pharmaceuticals Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 57.831 Cr | Rs. 126.912 Cr | Rs. 105.144 Cr | -17.15 % | + 81.81 % |
| Expenses | Rs. 55.98 Cr | Rs. 125.73 Cr | Rs. 101.42 Cr | -19.34 % | + 81.17 % |
| Operating Profit | Rs. 1.85 Cr | Rs. 1.18 Cr | Rs. 3.72 Cr | + 215.25 % | + 101.08 % |
| Net Profit | Rs. 0.79 Cr | Rs. 1.24 Cr | Rs. 1.6 Cr | + 29.03 % | + 102.53 % |
| EPS in Rs | Rs. 0.31 | Rs. 0.88 | Rs. 1.14 | + 29.55 % | + 267.74 % |
In reviewing Aarey Drugs & Pharmaceuticals Limited’s 2024-25(Q2) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 81.81 % year-on-year growth, although there was a slight dip of -17.15 % from the previous quarter. Expenses rose by 81.17 % compared to the previous year, with a decrease of -19.34 % quarter-on-quarter. Operating Profit surged by 101.08 % annually, and saw a 215.25 % increase from the last quarter.
Net Profit showed yearly increase of 102.53 %, and experienced a 29.03 % increase from the previous quarter. Earnings Per Share (EPS) rose by 267.74 % annually, however rose by 29.55 % compared to the last quarter. In essence, while Aarey Drugs & Pharmaceuticals Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
[my_shortcode1 values=”Aarey Drugs & Pharmaceuticals Limited”]
